» Authors » Adithya Cattamanchi

Adithya Cattamanchi

Explore the profile of Adithya Cattamanchi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 213
Citations 4346
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Huddart S, Yadav V, Sieberts S, Omberg L, Raberahona M, Rakotoarivelo R, et al.
Sci Data . 2024 Oct; 11(1):1149. PMID: 39424635
Cough is a common and commonly ignored symptom of lung disease. Cough is often perceived as difficult to quantify, frequently self-limiting, and non-specific. However, cough has a central role in...
12.
Holtgrewe L, Jain S, Dekova R, Broger T, Isaacs C, Theron G, et al.
J Clin Med . 2024 Oct; 13(19). PMID: 39407954
Rapid and accurate point-of-care (POC) tuberculosis (TB) diagnostics are crucial to bridge the TB diagnostic gap. Leveraging recent advancements in COVID-19 diagnostics, we explored adapting commercially available POC SARS-CoV-2 tests...
13.
Musinguzi A, Kasidi J, Kadota J, Welishe F, Nakitende A, Akello L, et al.
medRxiv . 2024 Sep; PMID: 39314926
Three months of isoniazid-rifapentine (3HP) is being scaled up for tuberculosis (TB) preventive treatment (TPT) among people living with HIV (PLHIV) in high-burden settings. More evidence is needed to identify...
14.
Kerkhoff A, West N, Castro M, Branigan D, Christopher D, Denkinger C, et al.
BMC Glob Public Health . 2024 Sep; 1(1). PMID: 39239641
To reach the millions of people with tuberculosis (TB) undiagnosed each year, there is an important need to provide people-centered screening and testing services. Despite people-centered care being a key...
15.
Kadota J, Musinguzi A, Aschmann H, Akello L, Welishe F, Nakimuli J, et al.
medRxiv . 2024 Aug; PMID: 39148841
Background: Short-course tuberculosis (TB) prevention regimens, including 12 weeks of isoniazid and rifapentine (3HP), are increasingly used in high TB-burden countries. Despite established safety and tolerability in efficacy trials, 3HP-related...
16.
Crowder R, Thangakunam B, Andama A, Christopher D, Dalay V, Dube-Nwamba W, et al.
medRxiv . 2024 Jul; PMID: 38947093
Background: Accessible, accurate screening tests are necessary to advance tuberculosis (TB) case finding and early detection in high-burden countries. We compared the diagnostic accuracy of available TB triage tests. Methods:...
17.
Holtgrewe L, Jain S, Dekova R, Broger T, Isaacs C, Nahid P, et al.
medRxiv . 2024 Jul; PMID: 38947060
Introduction: Rapid and accurate point-of-care (POC) tuberculosis (TB) diagnostics are a key priority to close the TB diagnostic gap of 3.1 million people without a diagnosis. Leveraging the recent surge...
18.
Worodria W, Castro R, Kik S, Dalay V, Derendinger B, Festo C, et al.
medRxiv . 2024 Jul; PMID: 38946949
Background: Computer-aided detection (CAD) algorithms for automated chest X-ray (CXR) reading have been endorsed by the World Health Organization for tuberculosis (TB) triage, but independent, multi-country assessment and comparison of...
19.
Broger T, Marx F, Theron G, Marais B, Nicol M, Kerkhoff A, et al.
Lancet Glob Health . 2024 Jun; 12(7):e1184-e1191. PMID: 38876764
Better access to tuberculosis testing is a key priority for fighting tuberculosis, the leading cause of infectious disease deaths in people. Despite the roll-out of molecular WHO-recommended rapid diagnostics to...
20.
Chang A, Loy C, Eweis-LaBolle D, Lenz J, Steadman A, Andgrama A, et al.
Nat Commun . 2024 Jun; 15(1):4949. PMID: 38858368
Tuberculosis (TB) remains a leading cause of death from an infectious disease worldwide, partly due to a lack of effective strategies to screen and triage individuals with potential TB. Whole...